- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Drug interactions (Cytochrome P450 and p-glycoprotein)
Total 473424 results
-
Mutual Pharmaceutical Company, Inc.CompletedHealthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoproteinUnited States
-
Eisai Inc.Completed
-
National Institute on Alcohol Abuse and Alcoholism...SuspendedOverweight | Healthy VolunteersUnited States
-
Jules DesmeulesCompletedHealthy VolunteersSwitzerland
-
Karl Landsteiner Institute for Systematics in General...CompletedDisorder Due Cytochrome P450 CYP2D6 VariantAustria
-
National Institutes of Health Clinical Center (CC)CompletedHIV Infections | HealthyUnited States
-
H. Lundbeck A/SCompletedCytochrome P450 InteractionUnited Kingdom, United States
-
Advocate Health CareCompletedDelirium, Cytochrome P-450 Enzyme SystemUnited States
-
University of CologneUmm Al-Qura UniversityCompletedAOD Effects and ConsequencesGermany
-
Sumitomo Pharma America, Inc.CompletedDrug-drug InteractionsUnited States
-
Weill Medical College of Cornell UniversityCompletedKidney Failure, ChronicUnited States
-
Boehringer IngelheimCompleted
-
University of GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedDepressive Disorder | Depression | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 VariantNetherlands
-
Boehringer IngelheimCompleted
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Columbia UniversityGlaxoSmithKline; American Epilepsy Society; Milken InstituteTerminatedEpilepsyUnited States
-
National Institute of Mental Health (NIMH)CompletedParkinson Disease | Alzheimer Disease | Frontotemporal Lobar DegenerationUnited States
-
University of UtahCubist Pharmaceuticals LLCCompletedPharmacokinetics | Drug InteractionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedAnovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 VariantGermany
-
AstraZenecaParexelCompletedHealthy ParticipantsUnited States
-
Royal Marsden NHS Foundation TrustUniversity of Brighton; Pharmacy Research UKUnknown
-
Hanmi Pharmaceutical Company LimitedCompletedHealthyKorea, Republic of
-
Washington University School of MedicineCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPoor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantBrazil
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedKidney Neoplasms | Neoplasm MetastasisUnited States
-
Boehringer IngelheimCompleted
-
Sony TutejaAmerican College of Clinical PharmacyCompletedKidney TransplantationUnited States
-
CelgeneCompletedHealthy VolunteerUnited States
-
University Medical Center GroningenNot yet recruiting
-
Dongyang LiuRecruitingHealth, Subjective | Nonvalvular Atrial FibrillationChina
-
National Institutes of Health Clinical Center (CC)National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Eli Lilly and CompanyActive, not recruitingUlcerative ColitisSpain, United States, China, Australia, Austria, Belgium, France, Italy, United Kingdom, Japan, Hungary, India, Serbia, Taiwan, Russian Federation, Canada, Korea, Republic of, Switzerland, Argentina, Israel, Latvia, Poland, Ukraine, D... and more
-
University of GuadalajaraCompletedHuman Immunodeficiency VirusMexico
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
National Institute of Mental Health (NIMH)Completed
-
University of GuadalajaraCompletedImpaired Glucose ToleranceMexico
-
Nutrition 21, Inc.CompletedEfficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DMDiabetes Mellitus, Type 2
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited States, Spain
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy VolunteersFrance
-
National Institutes of Health Clinical Center (CC)Completed
-
Eli Lilly and CompanyRecruitingInflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis | Ulcerative Colitis ChronicUnited States, Japan, Korea, Republic of, Austria, Netherlands, Belgium, France, Poland, Spain, Italy, Germany
-
Eli Lilly and CompanyActive, not recruitingUlcerative ColitisSpain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
-
Charite University, Berlin, GermanyUnknownObesity | Diabetes Mellitus, Type 1 | Healthy SubjectsGermany
-
CTI BioPharmaPPDCompletedDrug InteractionsUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States